Yiqun S. Du

Shanghai, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications

Safety and efficacy of bovine pericardial patch wrapping of the hepatic artery for preventing delayed postpancreatectomy hemorrhage after laparoscopic pancreaticoduodenectomy

Safety and efficacy of bovine pericardial patch wrapping of the hepatic artery for preventing delayed postpancreatectomy hemorrhage after laparoscopic pancreaticoduodenectomy

Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]
Published: June 25, 2026

Reduced/No Dexamethasone With Netupitant/Palonosetron and Olanzapine for Chemotherapy‑Induced Nausea/Vomiting in Highly Emetogenic Chemotherapy: Phase III Noninferiority Trial.

Reduced/No Dexamethasone With Netupitant/Palonosetron and Olanzapine for Chemotherapy‑Induced Nausea/Vomiting in Highly Emetogenic Chemotherapy: Phase III Noninferiority Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 04, 2026

Analysis of risk factors for postoperative recurrence and fecal incontinence in complex anal fistula based on MRI anatomic features

Analysis of risk factors for postoperative recurrence and fecal incontinence in complex anal fistula based on MRI anatomic features

Journal: Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery
Published: March 19, 2026

Results and Exploratory Biomarker Analyses of a Phase II Study CHANGEABLE: Combination of PD-1 Inhibitor and Niraparib in GErm-Line-mutAted Metastatic Breast Cancer.

Results and Exploratory Biomarker Analyses of a Phase II Study CHANGEABLE: Combination of PD-1 Inhibitor and Niraparib in GErm-Line-mutAted Metastatic Breast Cancer.

Journal: MedComm
Published: July 16, 2025

A Phase I open-label study to assess the pharmacokinetics, safety, and tolerability of capivasertib alone or in combination with paclitaxel in Chinese patients with advanced solid tumors.

A Phase I open-label study to assess the pharmacokinetics, safety, and tolerability of capivasertib alone or in combination with paclitaxel in Chinese patients with advanced solid tumors.

Journal: BMC cancer
Published: June 17, 2025

Granisetron transdermal delivery system versus palonosetron in the prevention of long-delayed nausea and vomiting: a phase III randomized trial.

Granisetron transdermal delivery system versus palonosetron in the prevention of long-delayed nausea and vomiting: a phase III randomized trial.

Journal: The oncologist
Published: May 25, 2025

Study on the Application of MLPA Detection for Large Fragment Loss of Mismatch Repair Genes in Chinese HNPCC Families.

Study on the Application of MLPA Detection for Large Fragment Loss of Mismatch Repair Genes in Chinese HNPCC Families.

Journal: Discovery medicine
Published: March 21, 2025

Retraction Note: MicroRNA-143 targets MAPK3 to regulate the proliferation and bone metastasis of human breast cancer cells.

Retraction Note: MicroRNA-143 targets MAPK3 to regulate the proliferation and bone metastasis of human breast cancer cells.

Journal: AMB Express
Published: December 28, 2024

First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors.

First-in-human study of DP303c, a HER2-targeted antibody-drug conjugate in patients with HER2 positive solid tumors.

Journal: NPJ precision oncology
Published: March 31, 2024

The RRP9-JUN axis promotes breast cancer progression via the AKT signalling pathway.

The RRP9-JUN axis promotes breast cancer progression via the AKT signalling pathway.

Journal: Biology direct
Published: February 02, 2024

Chinese physician perception on the treatment of chemotherapy-induced anemia: online cross-section survey study.

Chinese physician perception on the treatment of chemotherapy-induced anemia: online cross-section survey study.

Journal: Chinese clinical oncology
Published: January 22, 2024

Clinical characteristics and treatment outcomes of HER2 mutation and HER2 fusion in 22 patients with advanced breast cancer.

Clinical characteristics and treatment outcomes of HER2 mutation and HER2 fusion in 22 patients with advanced breast cancer.

Journal: Thoracic cancer
Published: August 15, 2023
Showing 1-12 of 32

Last Updated: 09/26/2026